Bristol James Arthur
- SEC CIK
- 0001715153
No open-market purchases or sales filed in the past year.
Current role at each company
- ERNA Ernexa Therapeutics Inc.Directoras of Sep 1, 2026
- ERAS Erasca, Inc.Directoras of Jun 29, 2026
- DCPH Deciphera Pharmaceuticals, Inc.Directoras of Jun 11, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bristol James Arthur as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ERAS Erasca, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2022 (view filing) | Dec 21 | 1 day | Bristol James ArthurDirector | PPurchase | +20.0K | $4.14 | +$82.8K | New position20.0K after |